{"id":197523,"date":"2025-11-24T11:48:11","date_gmt":"2025-11-24T11:48:11","guid":{"rendered":"https:\/\/www.europesays.com\/ie\/197523\/"},"modified":"2025-11-24T11:48:11","modified_gmt":"2025-11-24T11:48:11","slug":"novo-nordisk-shares-plunge-after-alzheimers-drug-trial-fails-to-hit-key-target","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ie\/197523\/","title":{"rendered":"Novo Nordisk shares plunge after Alzheimer&#8217;s drug trial fails to hit key target"},"content":{"rendered":"<p>The Novo Nordisk A\/S headquarters in Bagsvaerd, Denmark, on Wednesday, Nov. 5, 2025. <\/p>\n<p>Nichlas Pollier | Bloomberg | Getty Images<\/p>\n<p>Shares of Novo Nordisk on Monday fell as much 11% after the Danish drug pharmaceutical company said a highly-anticipated trial for Alzheimer&#8217;s disease failed to meet its main goal.<\/p>\n<p>The trial tested whether semaglutide\u00a0&#8212; the active ingredient in Novo&#8217;s blockbuster diabetes and weight loss drugs Ozempic and Wegovy &#8212; helped slow progression for Alzheimer&#8217;s disease. <\/p>\n<p><strong>This is breaking news. Please refresh for updates.<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"The Novo Nordisk A\/S headquarters in Bagsvaerd, Denmark, on Wednesday, Nov. 5, 2025. Nichlas Pollier | Bloomberg |&hellip;\n","protected":false},"author":2,"featured_media":197524,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[275],"tags":[4623,79,207,18,135,475,11588,474,19,17,2900],"class_list":{"0":"post-197523","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-healthcare","8":"tag-breaking-news-europe","9":"tag-business","10":"tag-business-news","11":"tag-eire","12":"tag-health","13":"tag-health-care","14":"tag-health-care-industry","15":"tag-healthcare","16":"tag-ie","17":"tag-ireland","18":"tag-pharmaceuticals"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ie\/115604521189675758","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/197523","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/comments?post=197523"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/197523\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media\/197524"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media?parent=197523"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/categories?post=197523"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/tags?post=197523"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}